Harvard Catalyst Profiles

Contact, publication, and social network information about Harvard faculty and fellows.

Michael Seth Rabin, M.D.

Title
Institution
Department
Address
Fax

Bibliographic
Publications listed below are automatically derived from MEDLINE/PubMed and other sources, which might result in incorrect or missing publications. Faculty can login to make corrections and additions.
Newest   |   Oldest   |   Most Cited   |   Most Discussed   |   Timeline   |   Field Summary   |   Plain Text
PMC Citations indicate the number of times the publication was cited by articles in PubMed Central, and the Altmetric score represents citations in news articles and social media. (Note that publications are often cited in additional ways that are not shown here.) Fields are based on how the National Library of Medicine (NLM) classifies the publication's journal and might not represent the specific topic of the publication. Translation tags are based on the publication type and the MeSH terms NLM assigns to the publication. Some publications (especially newer ones and publications not in PubMed) might not yet be assigned Field or Translation tags.) Click a Field or Translation tag to filter the publications.
  1. Sequist LV, Fidias PM, Temel JS, Kolevska T, Rabin MS, Boccia RV, Burris HA, Belt RJ, Huberman MS, Melnyk O, Mills GM, Englund CW, Caldwell DC, Keck JG, Meng L, Jones M, Brown GL, Edelman MJ, Lynch TJ. Phase 1-2a multicenter dose-ranging study of canfosfamide in combination with carboplatin and paclitaxel as first-line therapy for patients with advanced non-small cell lung cancer. J Thorac Oncol. 2009 Nov; 4(11):1389-96. PMID: 19701107.
    Citations: 5     Fields:    Translation:HumansCTClinical Trials
  2. Caglar HB, Baldini EH, Othus M, Rabin MS, Bueno R, Sugarbaker DJ, Mentzer SJ, Jänne PA, Johnson BE, Allen AM. Outcomes of patients with stage III nonsmall cell lung cancer treated with chemotherapy and radiation with and without surgery. Cancer. 2009 Sep 15; 115(18):4156-66. PMID: 19551884.
    Citations: 11     Fields:    Translation:Humans
  3. Allen AM, Mentzer SJ, Yeap BY, Soto R, Baldini EH, Rabin MS, Sugarbaker DJ, Bueno R. Pneumonectomy after chemoradiation: the Dana-Farber Cancer Institute/Brigham and Women's Hospital experience. Cancer. 2008 Mar 01; 112(5):1106-13. PMID: 18286507.
    Citations: 8     Fields:    Translation:Humans
  4. Allen AM, Rabin MS, Reilly JJ, Mentzer SJ. Unresectable adenoid cystic carcinoma of the trachea treated with chemoradiation. J Clin Oncol. 2007 Dec 01; 25(34):5521-3. PMID: 18048830.
    Citations: 11     Fields:    Translation:Humans
  5. Jackman DM, Yeap BY, Lindeman NI, Fidias P, Rabin MS, Temel J, Skarin AT, Meyerson M, Holmes AJ, Borras AM, Freidlin B, Ostler PA, Lucca J, Lynch TJ, Johnson BE, Jänne PA. Phase II clinical trial of chemotherapy-naive patients > or = 70 years of age treated with erlotinib for advanced non-small-cell lung cancer. J Clin Oncol. 2007 Mar 01; 25(7):760-6. PMID: 17228019.
    Citations: 101     Fields:    Translation:HumansCTClinical Trials
  6. Jackman DM, Yeap BY, Sequist LV, Lindeman N, Holmes AJ, Joshi VA, Bell DW, Huberman MS, Halmos B, Rabin MS, Haber DA, Lynch TJ, Meyerson M, Johnson BE, Jänne PA. Exon 19 deletion mutations of epidermal growth factor receptor are associated with prolonged survival in non-small cell lung cancer patients treated with gefitinib or erlotinib. Clin Cancer Res. 2006 Jul 01; 12(13):3908-14. PMID: 16818686.
    Citations: 160     Fields:    Translation:Humans
  7. Lo WK, vansonnenberg E, Shankar S, Morrison PR, Silverman SG, Tuncali K, Rabin M. Percutaneous CT-guided radiofrequency ablation of symptomatic bilateral adrenal metastases in a single session. J Vasc Interv Radiol. 2006 Jan; 17(1):175-9. PMID: 16415149.
    Citations: 8     Fields:    Translation:Humans
  8. Johnson BE, Rabin MS. Patient subsets benefiting from adjuvant therapy following surgical resection of non-small cell lung cancer. Clin Cancer Res. 2005 Jul 01; 11(13 Pt 2):5022s-5026s. PMID: 16000607.
    Citations: 3     Fields:    Translation:Humans
  9. Zygmanski P, Gall KP, Rabin MS, Rosenthal SJ. The measurement of proton stopping power using proton-cone-beam computed tomography. Phys Med Biol. 2000 Feb; 45(2):511-28. PMID: 10701518.
    Citations: 12     Fields:    
  10. Hetherington CJ, Kingsley PD, Crocicchio F, Zhang P, Rabin MS, Palis J, Zhang DE. Characterization of human endotoxin lipopolysaccharide receptor CD14 expression in transgenic mice. J Immunol. 1999 Jan 01; 162(1):503-9. PMID: 9886426.
    Citations: 4     Fields:    Translation:HumansAnimalsCells
  11. Mohan V, Kemp JA, Lewine HE, Rabin M, Goldstein ML, Farraye FA. Diffuse mesenteric amyloidosis. Dig Dis Sci. 1997 May; 42(5):1079-82. PMID: 9149066.
    Citations: 2     Fields:    Translation:Humans
  12. Mauch PM, Canellos GP, Shulman LN, Silver B, Tarbell NJ, Come S, Rabin MS, Coleman CN. Mantle irradiation alone for selected patients with laparotomy-staged IA to IIA Hodgkin's disease: preliminary results of a prospective trial. J Clin Oncol. 1995 Apr; 13(4):947-52. PMID: 7707123.
    Citations:    Fields:    Translation:HumansCTClinical Trials
  13. Kemper RR, Ahn ER, Zhang P, Lee MY, Rabin M. Human DNA polymerase delta gene maps to region 19q13.3-q13.4 by in situ hybridization. Genomics. 1992 Sep; 14(1):205-6. PMID: 1427831.
    Citations: 4     Fields:    Translation:HumansCells
  14. Riddell SR, Rabin M, Geballe AP, Britt WJ, Greenberg PD. Class I MHC-restricted cytotoxic T lymphocyte recognition of cells infected with human cytomegalovirus does not require endogenous viral gene expression. J Immunol. 1991 Apr 15; 146(8):2795-804. PMID: 1707922.
    Citations: 58     Fields:    Translation:HumansCells
  15. Ravid K, Beeler DL, Rabin MS, Ruley HE, Rosenberg RD. Selective targeting of gene products with the megakaryocyte platelet factor 4 promoter. Proc Natl Acad Sci U S A. 1991 Feb 15; 88(4):1521-5. PMID: 1899930.
    Citations: 22     Fields:    Translation:AnimalsCells
  16. Rabin MS, Doherty PJ, Gottesman MM. The tumor promoter phorbol 12-myristate 13-acetate induces a program of altered gene expression similar to that induced by platelet-derived growth factor and transforming oncogenes. Proc Natl Acad Sci U S A. 1986 Jan; 83(2):357-60. PMID: 3455773.
    Citations: 26     Fields:    Translation:AnimalsCells
  17. Rabin MS, Gottesman MM. High frequency of mutation to tubercidin resistance in CHO cells. Somatic Cell Genet. 1979 Sep; 5(5):571-83. PMID: 294700.
    Citations: 8     Fields:    Translation:AnimalsCells
Local representatives can answer questions about the Profiles website or help with editing a profile or issues with profile data. For assistance with this profile: HMS/HSDM faculty should contact feedbackcatalyst.harvard.edu. For faculty or fellow appointment updates and changes, please ask your appointing department to contact HMS. For fellow personal and demographic information, contact HMS Human Resources at human_resourceshms.harvard.edu. For faculty personal and demographic information, contact HMS Office for Faculty Affairs at facappthms.harvard.edu.
Rabin's Networks
Click the
Explore
buttons for more information and interactive visualizations!
Concepts (141)
Explore
_
Co-Authors (23)
Explore
_
Similar People (60)
Explore
_
Same Department 
Explore
_
Physical Neighbors
_
Funded by the NIH National Center for Advancing Translational Sciences through its Clinical and Translational Science Awards Program, grant number UL1TR002541.